- Home
- Primary Care
- Highlights of the EMERGENT-3 Trial: Advancing Schizophrenia Treatment with Xanomeline-Trospium Chloride
8mo3 min read
Medical Article
Introduction Schizophrenia is a chronic psychiatric disorder characterized by positive, negative, and cognitive symptoms, presenting a substantial disease burden and a significant impact on the quality of life and functioning of affected individuals (1). Current antipsychotic therapies predominantly target dopamine D2 receptor antagonism and are as

Highlights of the EMERGENT-3 Trial: Advancing Schizophrenia Treatment with Xanomeline-Trospium Chloride
2885 Reached1 Comments
Similar Content

Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes

Case of Adolescent with Severe Macrocytic Anaemia
53247 Reached501 Comments51 Likes

Young Girl Presented with Irritability and Abnormal Behavior
2256 Reached10 Comments4 Likes

Male with Urethral Bleeding due to Insertion of Telephone Wire in Urethra
2466 Reached4 Comments6 Likes

Spinal Anesthesia in Elderly Patient
4213 Reached10 Comments7 Likes
